Quince Therapeutics Inc.
QNCX | NASDAQ
$32
+$1 (+3.23%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 59.04M | 71K | 35K | 51K | 51K | 16K | 16K | 304K | 304K | 304K | 304K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -59.04M | -71K | -35K | -51K | -51K | -16K | -16K | -304K | -304K | -304K | -304K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -65.98M | -53.79M | -57.54M | -48.29M | -40.73M | -59.02M | -55.38M | -53.62M | -53.85M | -31.24M | -32.98M | -30.95M | -32.48M | -43.15M | -52.06M | -69.29M | -83.34M | -88.87M | -90.32M | -87.63M | -87.86M | -84.35M |
Interest Income | 1.27M | 998K | 1.24M | 1.55M | 1.94M | 2.45M | 2.93M | 3.41M | 3.68M | 3.67M | 3.48M | 3M | 2.36M | 1.7M | 1.07M | 637K | 450K | 465K | 620K | 812K | 1.09M | 1.59M |
Pretax Income | -94.64M | -35.21M | -80.77M | -56.9M | -48.9M | -60.61M | -56.74M | -53.13M | -53.01M | -30.2M | -31.58M | -28.27M | -30.84M | -42.81M | -51.94M | -69.81M | -83.59M | -88.5M | -89.95M | -87.1M | -86.9M | -82.76M |
Net Income | -92.48M | -33.04M | -83.98M | -56.98M | -49.03M | -60.71M | -56.83M | -53.26M | -53.12M | -30.28M | -31.39M | -28.03M | -30.6M | -42.27M | -51.66M | -69.53M | -83.31M | -88.5M | -89.95M | -87.1M | -86.9M | -82.76M |
Selling & General & Admin | 27.81M | 14.53M | 15.05M | 15.68M | 16.03M | 17.38M | 17.56M | 17.9M | 18.93M | 18.47M | 17.33M | 16.27M | 15.95M | 20.78M | 26.06M | 30.84M | 34.14M | 32.14M | 29.52M | 26.19M | 23.48M | 20.6M |
Research & Development | 32.99M | 34.08M | 35.38M | 28.61M | 25.44M | 23.03M | 18.59M | 16.2M | 12.71M | 9.92M | 9.45M | 8.78M | 9.8M | 15.65M | 25.18M | 37.62M | 49.21M | 56.73M | 60.79M | 61.44M | 64.38M | 63.75M |
Other Expenses | 5.15M | 5.11M | 7.07M | 3.96M | -794K | 18.59M | 19.21M | 19.21M | 21.9M | 2.55M | 5.9M | 5.9M | 6.73M | 6.73M | 825K | 825K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 65.95M | 53.72M | 57.5M | 48.24M | 40.67M | 59.01M | 55.37M | 53.31M | 53.54M | 30.94M | 32.67M | 30.95M | 32.48M | 43.15M | 52.06M | 69.29M | 83.34M | 88.87M | 90.32M | 87.63M | 87.86M | 84.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 65.98M | 53.79M | 57.54M | 48.29M | 40.73M | 59.02M | 55.38M | 53.62M | 53.85M | 31.24M | 32.98M | 30.95M | 32.48M | 43.15M | 52.06M | 69.29M | 83.34M | 88.87M | 90.32M | 87.63M | 87.86M | 84.35M |
Income Tax Expense | -2.16M | -2.17M | 3.21M | 75K | 134K | 103K | 87K | 131K | 118K | 82K | -197K | -248K | -248K | -532K | -284K | -284K | -284K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 6.13M | 250.49K | 250.49K | 269.76K | 233.43K | 219.71K | 216.31K | 215.82K | 215.48K | 215.05K | 204.87K | 180.37K | 179.59K | 179.28K | 180.68K | 178.06K | 162.34K | 150.67K | 148.84K | 148.84K | 147.94K | 147.78K |
Shares Outstanding (Diluted) | 6.13M | 250.49K | 250.49K | 269.76K | 233.43K | 219.71K | 216.31K | 215.82K | 215.48K | 215.05K | 204.87K | 180.37K | 179.59K | 179.28K | 180.68K | 178.06K | 162.34K | 150.67K | 148.84K | 148.84K | 147.94K | 147.78K |
EPS (Basic) | -68.91 | -124.60 | -336 | -242 | -218 | -278 | -262 | -250 | -254 | -154 | -170 | -158 | -174 | -248 | -322 | -448 | -548 | -594 | -608 | -590 | -590 | -562 |
EPS (Diluted) | -68.91 | -124.60 | -336 | -242 | -218 | -278 | -262 | -250 | -254 | -154 | -170 | -158 | -174 | -248 | -322 | -448 | -548 | -594 | -608 | -590 | -590 | -562 |
EBITDA | -76.7M | -12.86M | -56.37M | -52.61M | -49.74M | -42.6M | -38.33M | -34.43M | -31.32M | -27.41M | -25.81M | -22.77M | -24.17M | -36.05M | -50.61M | -68.44M | -83.3M | -88.2M | -89.83M | -85.24M | -85.45M | -81.97M |
EBIT | -19.11M | -13.01M | -56.52M | -52.73M | -49.91M | -42.77M | -38.51M | -34.9M | -31.71M | -27.75M | -26.14M | -22.83M | -24.27M | -36.23M | -50.82M | -68.68M | -83.59M | -88.5M | -90.17M | -85.58M | -85.79M | -82.3M |
Depreciation & Amortization | 152K | 146K | 142K | 119K | 169K | 178K | 186K | 474K | 388K | 345K | 322K | 60K | 100K | 183K | 204K | 246K | 293K | 296K | 344K | 345K | 342K | 335K |
Add to Watchlist
Select watchlists to add or remove QNCX